Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy
Finally, antiviral drug for dengue in the offing
World’s first botanical drug against dengue is in the final stage of development at the Delhi-based International Centre for Genetic …
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
Sun Pharma to buy troubled giant Ranbaxy
The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company
Karnataka receives lowest solar energy tariff bid till date
Sun Pharma bags solar project by quoting Rs 5.51 per unit; previous lowest bid was for Rs 7 in Odisha